Skip to main content
SpringerLink
Log in

Effect of the acute sublingual administration of ketanserin in hypertensive patients

  • Hypertension
  • Published:
Cardiovascular Drugs and Therapy Aims and scope Submit manuscript

Summary

The purpose of this study has been to compare the acute antihypertensive effect of a dose of 20 mg of ketanserin in 18 patients after sublingual administration and in 19 after oral administration. In three patients ketanserin and ketanserin-ol plasma levels were measured after both sublingual and oral administration. The results showed a more rapid, considerable antihypertensive effect after sublingual administration. In addition, the high plasma levels of ketanserin-ol, the metabolite produced by hepatic reduction of ketanserin, reached after sublingual administration, rather than transmucosal absorption, indicate that the clinical effect observed is due to more rapid dissolution of the tablet formulation and liberation of the active drug.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Fozard JR. Mechanism of the hyportensive effect of ketanserin.J Cardiovasc Pharmacol 1982;4:829–838.

    Article  PubMed  CAS  Google Scholar 

  2. Wenting GJ, Woittiez AJJ, Man in’t Veld AJ, et al. 5HT, alpha adrenoceptors and blood pressure. Effects of ketanserin in essential hypertension and autonomic insufficiency.Hypertension 1984;6:100–109

    PubMed  CAS  Google Scholar 

  3. Kurowski M. Bioavailability and pharmacokinetics of ketanserin in elderly subjects.Eur J Clin Pharmacol 1985;28: 411–417.

    Article  PubMed  CAS  Google Scholar 

  4. Reimann IW, Okonkwo PO, Klotz U. Pharmacokinetics of ketanserin in man.Eur J Clin Pharmacol 1983;25:73–76.

    Article  PubMed  CAS  Google Scholar 

  5. Okonkwo PO, Reimann IW, Woestenborghs R, et al. Highperformance liquid Chromatographie assay with fluorometric detection of ketanserin, a new antihypertensive agent and serotonin S2 antagonist, in human plasma, blood and urine.J Chromatogr 1983;272:411–416

    Article  PubMed  CAS  Google Scholar 

  6. Walker JM, Wilmshurst PT, Juul SM, et al. Acute effects of ketanserin on left ventricular function, metabolism and coronary flow.Br J Clin Pharmacol 1984;17:301–307.

    PubMed  CAS  Google Scholar 

  7. McGoutry JC, Silas HJ, Cowen KJ. Controlled trial of ketanserin in hypertension.Br J Clin Pharmacol 1985;20: 37–40.

    Google Scholar 

  8. Persson B, Hedner T, Berglund G. Ketanserin in essential hypertension. Effects during rest and exercise.Eur J Clin Pharmacol 1983;25:307–312.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. II Clinica Medica, University of Rome “La Sapienza”, Rome, Italy

    G. Aliberti, E. D’Erasmo, C. M. Oddo & E. Vecci

Authors
  1. G. Aliberti
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E. D’Erasmo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. M. Oddo
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. E. Vecci
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Aliberti, G., D’Erasmo, E., Oddo, C.M. et al. Effect of the acute sublingual administration of ketanserin in hypertensive patients. Cardiovasc Drug Ther 5, 697–699 (1991). https://doi.org/10.1007/BF03029743

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03029743

Key Words

Search

Navigation